- Home
- GHRS vs SENEB Comparison
GHRS vs SENEB Comparison
Compare GHRS & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- SENEB
- Stock Information
- Founded
- GHRS 2018
- SENEB 1949
- Country
- GHRS Ireland
- SENEB United States
- Employees
- GHRS N/A
- SENEB N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- SENEB Packaged Foods
- Sector
- GHRS Health Care
- SENEB Consumer Staples
- Exchange
- GHRS Nasdaq
- SENEB Nasdaq
- Market Cap
- GHRS 774.1M
- SENEB 720.7M
- IPO Year
- GHRS 2021
- SENEB N/A
- Fundamental
- Price
- GHRS $13.10
- SENEB $110.20
- Analyst Decision
- GHRS Strong Buy
- SENEB
- Analyst Count
- GHRS 8
- SENEB 0
- Target Price
- GHRS $30.63
- SENEB N/A
- AVG Volume (30 Days)
- GHRS 307.7K
- SENEB 628.0
- Earning Date
- GHRS 11-13-2025
- SENEB 11-05-2025
- Dividend Yield
- GHRS N/A
- SENEB N/A
- EPS Growth
- GHRS N/A
- SENEB N/A
- EPS
- GHRS N/A
- SENEB 6.24
- Revenue
- GHRS N/A
- SENEB $1,571,618,000.00
- Revenue This Year
- GHRS N/A
- SENEB N/A
- Revenue Next Year
- GHRS N/A
- SENEB N/A
- P/E Ratio
- GHRS N/A
- SENEB $17.56
- Revenue Growth
- GHRS N/A
- SENEB 7.30
- 52 Week Low
- GHRS $6.00
- SENEB $61.10
- 52 Week High
- GHRS $20.50
- SENEB $112.00
- Technical
- Relative Strength Index (RSI)
- GHRS 45.98
- SENEB 62.40
- Support Level
- GHRS $13.00
- SENEB $103.07
- Resistance Level
- GHRS $14.96
- SENEB $105.90
- Average True Range (ATR)
- GHRS 0.78
- SENEB 0.38
- MACD
- GHRS -0.00
- SENEB -0.13
- Stochastic Oscillator
- GHRS 28.46
- SENEB 100.00
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.